Literature DB >> 27195758

Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.

Edwin J Asturias1, Melinda Wharton2, Robert Pless3, Noni E MacDonald4, Robert T Chen5, Nicholas Andrews6, David Salisbury7, Alexander N Dodoo8, Kenneth Hartigan-Go9, Patrick L F Zuber10.   

Abstract

In 1999, the Global Advisory Committee on Vaccine Safety (GACVS) was established by the World Health Organization (WHO) to provide independent scientific advice on issues relating to the safety of vaccines and immunization. Fifteen years onward, we conducted a multi-faceted review to evaluate the impact, reach and challenges facing GACVS, including the role GACVS plays in informing global, regional and WHO member state vaccine policy. The methods included measures of organizational structure, citation impact, themes approached, and a discussion by previous and current members to evaluate past, present and future challenges. Given the increasing range of data sources and the deployment of many new vaccines, the Committee is facing the complex task of identifying the best available evidence for recommendations on vaccine safety. To help meet the increased demand for public transparency in decision making, GACVS-structured methodology for evidence-based decisions is evolving. GACVS also promotes best practices and capacity building for timely and accurate risk assessment; risk communications; outreach to help countries maintain and, if needed, rebuild public trust in vaccines; and advocacy for bridging the major gaps in vaccine safety capacity globally.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Global Advisory Committee on Vaccine Safety; Global public health; Immunization program; Vaccine adverse events; Vaccine policy; Vaccine safety

Mesh:

Substances:

Year:  2016        PMID: 27195758      PMCID: PMC5085263          DOI: 10.1016/j.vaccine.2016.05.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  40 in total

Review 1.  Vaccine safety: risk communication--a global perspective.

Authors:  S Dittmann
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

2.  Immunization safety priority project at the World Health Organization.

Authors:  Philippe Duclos; Alison Delo; Teresa Aguado; Julian Bilous; Maureen Birmingham; Marie Paule Kieny; Julie Milstien; David Wood; Daniel Tarantola
Journal:  Semin Pediatr Infect Dis       Date:  2003-07

3.  World Health Organization develops guidance for vaccine safety information on the web.

Authors: 
Journal:  Euro Surveill       Date:  2005-01-13

Review 4.  Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.

Authors: 
Journal:  Expert Rev Vaccines       Date:  2009-06       Impact factor: 5.217

5.  Vaccines and Internet: characteristics of the vaccine safety net web sites and suggested improvements.

Authors:  Marta Martínez-Mora; María José Alvarez-Pasquín; Francisco Rodríguez-Salvanés
Journal:  Vaccine       Date:  2008-10-23       Impact factor: 3.641

6.  More on RotaShield and intussusception: the role of age at the time of vaccination.

Authors:  L Simonsen; C Viboud; A Elixhauser; R J Taylor; A Z Kapikian
Journal:  J Infect Dis       Date:  2005-09-01       Impact factor: 5.226

7.  Intussusception among infants given an oral rotavirus vaccine.

Authors:  T V Murphy; P M Gargiullo; M S Massoudi; D B Nelson; A O Jumaan; C A Okoro; L R Zanardi; S Setia; E Fair; C W LeBaron; M Wharton; J R Livengood; J R Livingood
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

8.  Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus.

Authors:  Joseph G Victoria; Chunlin Wang; Morris S Jones; Crystal Jaing; Kevin McLoughlin; Shea Gardner; Eric L Delwart
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

9.  Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.

Authors:  A C Hesseling; H Rabie; B J Marais; M Manders; M Lips; H S Schaaf; R P Gie; M F Cotton; P D van Helden; R M Warren; N Beyers
Journal:  Clin Infect Dis       Date:  2006-01-11       Impact factor: 9.079

Review 10.  Bacillus Calmette-Guérin complications in children born to HIV-1-infected women with a review of the literature.

Authors:  K L O'Brien; A J Ruff; M A Louis; J Desormeaux; D J Joseph; M McBrien; J Coberly; R Boulos; N A Halsey
Journal:  Pediatrics       Date:  1995-03       Impact factor: 7.124

View more
  5 in total

1.  Vaccine safety: An evolving evidence-based science.

Authors:  Bruce M McClenathan; Kathryn M Edwards
Journal:  Br J Clin Pharmacol       Date:  2019-08-19       Impact factor: 4.335

2.  Overcoming barriers in HPV vaccination and screening programs.

Authors:  Alex Vorsters; Marc Arbyn; Marc Baay; Xavier Bosch; Silvia de Sanjosé; Sharon Hanley; Emilie Karafillakis; Pier Luigi Lopalco; Kevin G Pollock; Joanne Yarwood; Pierre Van Damme
Journal:  Papillomavirus Res       Date:  2017-07-20

3.  Tracking the progress in COVID-19 and vaccine safety research - a comprehensive bibliometric analysis of publications indexed in Scopus database.

Authors:  Tosin Yinka Akintunde; Shaojun Chen; Taha Hussein Musa; Felix Oluseyi Amoo; Adekunle Adedeji; Elhakim Ibrahim; Angwi Enow Tassang; Idriss Hussein Musa; Hassan Hussein Musa
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

4.  Profit considerations in vaccine safety-related events in China.

Authors:  Jianlin Zhuang; Yihan Lu; Abram L Wagner; Qingwu Jiang
Journal:  Expert Rev Vaccines       Date:  2019-11-13       Impact factor: 5.217

5.  The Model of "Informed Refusal" for Vaccination: How to Fight against Anti-Vaccinationist Misinformation without Disregarding the Principle of Self-Determination.

Authors:  Stefano D'Errico; Emanuela Turillazzi; Martina Zanon; Rocco Valerio Viola; Paola Frati; Vittorio Fineschi
Journal:  Vaccines (Basel)       Date:  2021-02-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.